Johnson & Johnson (JNJ)
265.81
-0.54
(-0.20%)
USD |
NYSE |
Sep 11, 13:46
Johnson & Johnson Gross Profit (TTM) : 66.63B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.63B |
| March 31, 2026 | 65.49B |
| December 31, 2025 | 64.02B |
| September 30, 2025 | 62.91B |
| June 30, 2025 | 61.73B |
| March 31, 2025 | 60.96B |
| December 31, 2024 | 61.03B |
| September 30, 2024 | 60.22B |
| June 30, 2024 | 59.51B |
| March 31, 2024 | 59.04B |
| December 31, 2023 | 58.68B |
| September 30, 2023 | 58.20B |
| June 30, 2023 | 57.29B |
| March 31, 2023 | 58.41B |
| December 31, 2022 | 59.98B |
| September 30, 2022 | 62.65B |
| June 30, 2022 | 64.89B |
| March 31, 2022 | 64.50B |
| December 31, 2021 | 63.88B |
| September 30, 2021 | 61.92B |
| June 30, 2021 | 59.97B |
| March 31, 2021 | 56.07B |
| December 31, 2020 | 54.57B |
| September 30, 2020 | 53.62B |
| June 30, 2020 | 53.37B |
| Date | Value |
|---|---|
| March 31, 2020 | 55.30B |
| December 31, 2019 | 54.98B |
| September 30, 2019 | 54.67B |
| June 30, 2019 | 54.38B |
| March 31, 2019 | 54.46B |
| December 31, 2018 | 54.35B |
| September 30, 2018 | 53.84B |
| June 30, 2018 | 52.94B |
| March 31, 2018 | 52.15B |
| December 31, 2017 | 51.23B |
| September 30, 2017 | 50.91B |
| June 30, 2017 | 50.46B |
| March 31, 2017 | 50.54B |
| December 31, 2016 | 50.30B |
| September 30, 2016 | 49.89B |
| June 30, 2016 | 49.50B |
| March 31, 2016 | 48.77B |
| December 31, 2015 | 48.62B |
| September 30, 2015 | 48.82B |
| June 30, 2015 | 49.91B |
| March 31, 2015 | 50.85B |
| December 31, 2014 | 51.38B |
| September 30, 2014 | 51.36B |
| June 30, 2014 | 50.49B |
| March 31, 2014 | 49.48B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Eli Lilly & Co. | 66.44B |
| Merck & Co., Inc. | 48.01B |
| Pfizer Inc. | 41.30B |
| Bristol Myers Squibb Co. | 32.78B |
| Liquidia Corp. | 416.18M |